# Brio Pharmaceuticals Inc – FDA Inspection, Feb 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/brio-pharmaceuticals-inc/215855d7-cef6-4306-9ed7-1cf6d2c8aaba
Source feed: FDA_Inspections

> FDA inspection 1304746 of Brio Pharmaceuticals Inc, February 27, 2026. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304746
- Company Name: Brio Pharmaceuticals Inc
- Inspection Date: 2026-02-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1323564 - 2026-06-19
- [FDA Inspection 1096432 - 2019-07-11](https://www.keypedia.com/records/fda_inspections/brio-pharmaceuticals-inc/e7bb136f-ec6b-4d21-82ff-c94f3b0fb2de)
- [FDA Inspection 1067624 - 2018-10-03](https://www.keypedia.com/records/fda_inspections/brio-pharmaceuticals-inc/6b3e020d-fad5-4221-94c5-449b85ed6600)
- [FDA Inspection 1011466 - 2017-04-26](https://www.keypedia.com/records/fda_inspections/brio-pharmaceuticals-inc/fa735a23-bad8-4360-be86-c3c74fa85bd7)
- [FDA Inspection 929358 - 2015-06-01](https://www.keypedia.com/records/fda_inspections/brio-pharmaceuticals-inc/816420e3-8f8d-434d-ab58-10422385cb31)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/timothy-h-vo/08da7ca5-7f58-42bf-8046-e3a1bf879b48)

Company: https://www.keypedia.com/companies/brio-pharmaceuticals-inc/7de121f3-b46f-42fb-90c0-ee912764ab9b

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
